These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11885591)

  • 21. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza season triggers pneumococcal vaccination.
    Goebel LJ; Mufson MA
    J Am Geriatr Soc; 2006 Aug; 54(8):1261-4. PubMed ID: 16913996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunization promotion in adults and the elderly: needs, evidence, and operative proposals for health services].
    Piffer S; Moghadam PF
    Ann Ig; 2002; 14(3 Suppl 3):83-92. PubMed ID: 12389415
    [No Abstract]   [Full Text] [Related]  

  • 24. The number needed to vaccinate (NNV) and population extensions of the NNV: comparison of influenza and pneumococcal vaccine programmes for people aged 65 years and over.
    Kelly H; Attia J; Andrews R; Heller RF
    Vaccine; 2004 Jun; 22(17-18):2192-8. PubMed ID: 15149776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [An antipneumococcal vaccination program for the elderly of Bologna].
    Roveri P; Faggioli A; Gianninoni AR; Agostini D
    Ann Ig; 1999; 11(4):319-27. PubMed ID: 10520525
    [No Abstract]   [Full Text] [Related]  

  • 26. Cost-effectiveness analysis of influenza and pneumococcal vaccinations among elderly people in Japan.
    Cai L; Uchiyama H; Yanagisawa S; Kamae I
    Kobe J Med Sci; 2006; 52(3-4):97-109. PubMed ID: 16855372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HHS Unveils two new efforts to advance pandemic flu awareness.
    FDA Consum; 2007; 41(2):11. PubMed ID: 17582860
    [No Abstract]   [Full Text] [Related]  

  • 28. Influenza vaccination cost effective in U.S. adults.
    Geriatrics; 2006 Feb; 61(2):14. PubMed ID: 16502520
    [No Abstract]   [Full Text] [Related]  

  • 29. Racial and ethnic disparities in Medicare: what the Department of Health and Human Services and the Centers for Medicare and Medicaid Services can, and should, do.
    Jost TS
    DePaul J Health Care Law; 2005; 9(1):667-718. PubMed ID: 17061383
    [No Abstract]   [Full Text] [Related]  

  • 30. Influenza vaccination coverage in old people's homes in central Auckland.
    Calder L
    N Z Med J; 1994 May; 107(978):202. PubMed ID: 8196866
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacoeconomics of elderly vaccination against invasive pneumococcal infections: cost-effectiveness analyses and implications for The Netherlands.
    Postma MJ; Heijnen ML; Beutels P; Jager JC
    Expert Rev Vaccines; 2003 Aug; 2(4):477-82. PubMed ID: 14711333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring temps. As healthcare agencies wait for permanent leaders, acting heads take on H1N1 flu virus.
    Zigmond J
    Mod Healthc; 2009 May; 39(18):7, 16. PubMed ID: 19472500
    [No Abstract]   [Full Text] [Related]  

  • 33. From the Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination coverage levels among persons aged > or = 65 years--United States, 1973-1993.
    JAMA; 1995 Aug; 274(7):530-1. PubMed ID: 7629971
    [No Abstract]   [Full Text] [Related]  

  • 34. Plans feel pressure to vaccinate more adults. The cost-effectiveness of prevention is undeniable, yet vaccination rates for everything but influenza decline.
    Sipkoff M
    Manag Care; 2008 Aug; 17(8):32-4. PubMed ID: 18777787
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pneumococcal vaccination for persons 65 years of age and older].
    van den Bosch WJ
    Ned Tijdschr Geneeskd; 2002 May; 146(18):838-9. PubMed ID: 12038219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Policy evaluation for the subsidy for influenza vaccination in elderly.
    Ohkusa Y
    Vaccine; 2005 Mar; 23(17-18):2256-60. PubMed ID: 15755606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza and pneumococcal vaccination of adults aged > or = 65: racial/ethnic differences.
    Singleton JA; Santibanez TA; Wortley PM
    Am J Prev Med; 2005 Dec; 29(5):412-20. PubMed ID: 16376704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practice-proven interventions to increase vaccination rates and broaden the immunization season.
    Stinchfield PK
    Am J Med; 2008 Jul; 121(7 Suppl 2):S11-21. PubMed ID: 18589063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influenza vaccination and self-reported reasons for not receiving influenza vaccination among Medicare beneficiaries aged > or =65 years--United States, 1991-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(43):1012-5. PubMed ID: 15525898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of vaccinating for invasive pneumococcal disease in the elderly in the Lazio region of Italy.
    Merito M; Giorgi Rossi P; Mantovani J; Curtale F; Borgia P; Guasticchi G
    Vaccine; 2007 Jan; 25(3):458-65. PubMed ID: 17049685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.